Add Life Medical Institute Ltd. (a.k.a. Sterling), a Gujarat, India-based hospital group, has raised $15.5 million in growth capital funding from Actis. www.act.is
Concert Pharmaceuticals Inc., a Boston-based drug development company using novel chemistry approaches, has raised $10 million in Series A funding, according to a regulatory filing. Backers include Three Arch Partners and Skyline Ventures.
DecisionView Inc., a San Francisco-based provider of software solutions that help optimize clinical drug trials, has secured $7.73 million of a $12.47 million Series B round, according to a regulatory filing. Adobe Ventures was joined by return backers Partech International and Granite Ventures. www.decisionviewsoftware.com
Synta Pharmaceuticals Corp., a Lexington, Mass.-based small-molecule drug company, has raised $40 million in fifth-round funding. A regulatory filing refers to the securities as Series A convertible preferred stock, with Caxton Corp. and Luxor Capital Partners listed as significant shareholders. SunAmerica Ventures also participated. Synta has raised over $230 million in total VC funding since its 2001 inception. www.syntapharma.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: